Systemic Inflammation Indexing is the clinical practice of aggregating and analyzing a panel of inflammatory biomarkers—such as high-sensitivity C-Reactive Protein (hs-CRP), fibrinogen, and various cytokines—to derive a composite score that quantifies the overall chronic, low-grade inflammatory burden in the body. This index serves as a powerful predictor of chronic disease risk and a critical metric for monitoring the effectiveness of anti-inflammatory interventions. It moves beyond single-marker assessment to capture the complex, multi-faceted inflammatory landscape.
Origin
This concept stems from immunology and preventative cardiology, recognizing that chronic systemic inflammation, often subclinical, is a common pathway linking metabolic dysfunction, hormonal imbalance, and age-related pathology. The indexing approach provides a holistic, single-figure view of this pervasive underlying threat to health.
Mechanism
The index operates by integrating multiple inflammatory signals, providing a more robust measure of endothelial and tissue stress than any single marker alone could offer. Elevated indexing scores signal an overactive innate immune response, which can drive insulin resistance and hormonal clearance issues. Therapeutic interventions, including dietary changes and targeted nutraceuticals, are then deployed to systematically reduce this inflammatory load, thereby improving metabolic and endocrine function and reducing overall disease risk.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.